Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Premature Birth 1Patient Compliance 1Neoplasms 1Hirschsprung Disease 1Heart Defects, Congenital 1Congenital Abnormalities 1Child Nutrition Disorders 1Acquired Immunodeficiency Syndrome 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Self Care × 90 days × Clear all
NCT04150120 2026-04-06

eChildHealth

Lund University

Phase NA Completed
720 enrolled

Congenital Abnormalities, Acquired Immunodeficiency Syndrome, Heart Defects, Congenital, Hirschsprung Disease, Neoplasms, Patient Compliance, Child Nutrition Disorders, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡